CVS Health Corp.

CVS Health Corp. faced a significant decline in stock value, contrasting with the S&P 500's gains. Despite recent challenges, the company has shown a year-over-year return exceeding the index. Financial metrics indicate a market cap of USD 129,929 million and a price-to-earnings ratio of 23.00, reflecting its complex market position.

CVS Health Corp. saw a significant stock decline today, contrasting with the stable S&P 500. Despite a recent downturn, CVS has outperformed the index annually and maintains a strong market position with a high institutional ownership rate and consistent long-term sales growth.

CVS Health Corp. opened with a significant stock price decline, contrasting with the S&P 500's stability. The company has a market capitalization of approximately USD 118.76 billion, a P/E ratio of 17.00, and a notable dividend yield. Financial metrics indicate mixed technical indicators as CVS adapts to market conditions.

CVS Health Corp. achieved a new 52-week high of USD 85.15 on October 29, 2025, reflecting strong performance in the retail sector. The company has a market capitalization of USD 118.76 billion, a P/E ratio of 17.00, and a notable dividend yield, indicating solid financial health.

CVS Health Corp. has adjusted its valuation, showcasing a P/E ratio of 17 and a price-to-book value of 1.39. The company has a strong dividend yield and competitive returns compared to the S&P 500, although its long-term performance has been less favorable relative to the index.

CVS Health Corp. achieved a new 52-week high of USD 81.93 on October 15, 2025, reflecting strong performance in the retail sector. The company has seen a 33.83% growth over the past year, significantly outperforming the S&P 500, and maintains a solid financial position with a balanced debt-to-equity ratio.

CVS Health Corp. achieved a new 52-week high of USD 79.94 on October 14, 2025, reflecting strong performance in the retail sector. With a market cap of USD 118.76 billion, a P/E ratio of 17.00, and a dividend yield of 145.25%, the company demonstrates solid financial health and competitive valuation.

CVS Health Corp. achieved a new 52-week high, reflecting its strong performance in the retail sector with a notable annual increase. The company, classified as large-cap, has a market capitalization of USD 118,762 million, a P/E ratio of 17.00, and a solid dividend yield, showcasing its financial strength.

CVS Health Corp. achieved a new 52-week high of USD 79.20 on October 3, 2025, reflecting strong performance in the retail sector with a 28.55% increase over the past year. The company has a market cap of USD 118.76 billion and notable financial metrics, indicating a solid position in the industry.

CVS Health Corp. achieved a new 52-week high of USD 77.54 on October 1, 2025, reflecting strong performance in the retail sector with a 27.52% increase over the past year. The company has a market capitalization of USD 118,762 million and a P/E ratio of 17.00.

CVS Health Corp. achieved a new 52-week high, reflecting strong performance in the retail sector. With a market capitalization of approximately USD 118.76 billion, the company shows competitive valuation metrics, including a P/E ratio of 17.00 and a notable dividend yield, indicating a solid financial position.

CVS Health Corp. achieved a new 52-week high, reflecting strong performance in the retail sector with a one-year growth of 26.91%. The company, with a market cap of USD 118.76 billion, features a P/E ratio of 17.00 and a dividend yield of 145.25%, showcasing its financial strength.

CVS Health Corp. achieved a new 52-week high, reflecting strong performance in the retail sector with a notable annual increase. The company, with a market capitalization of USD 118.76 billion, demonstrates solid financial health through its P/E ratio, dividend yield, and balanced debt-to-equity ratio.